Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.
about
Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic painCrucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic painThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression ComorbidityA lipid gate for the peripheral control of pain"Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain controlCannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury painThe endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.Recent data on cannabinoids and their pharmacological implications in neuropathic pain.Peripheral gating of pain signals by endogenous lipid mediators.Cannabinoid-opioid interactions during neuropathic pain and analgesia.Puerarin alleviates neuropathic pain by inhibiting neuroinflammation in spinal cord.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideIncreased expression of cannabinoid CB₁ receptors in Achilles tendinosis.The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress.Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.Modulation of pain transmission by G-protein-coupled receptors.Cannabinoids inhibit acid-sensing ion channel currents in rat dorsal root ganglion neurons.Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain.Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative painThe endocannabinoid system and painThe highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.Koumine enhances spinal cord 3α-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain.Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathwaysCannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics folloEffects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in ratsThe endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons.Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats.Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain modelIncreased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer painTRPV1 Antagonists and Chronic Pain: Beyond Thermal PerceptionTargeting the endocannabinoid system: to enhance or reduce?Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
P2860
Q24634125-4DE42F4E-182A-4542-AF28-8EAF64ABB24DQ24634161-64DB4BA2-418F-4897-889D-85F6FDA01331Q24643876-8E9584F9-CA52-45D5-BA45-E69733270159Q26784030-B930AF97-63D6-4FB3-AC94-ED327DC1A689Q26995053-AEA26EAF-68B0-4CE2-BC5C-3F20AE0A661AQ27015753-33FB913A-F035-4F57-B194-FFFD855C0BD3Q28575056-1288FE19-CC48-4DC3-877C-A992DFF58D2FQ30455787-356DD8F1-5230-4363-BDC2-806A277377B8Q33527067-8D7B6F88-4CA4-4140-8761-2A696180E848Q33608432-3359545E-B94D-47EA-BFEE-E04A9090EDA2Q33637224-056D4BDC-8B3A-4481-B39C-102811CB929CQ33894072-18CDC515-CB2E-4ED5-95CB-9D63F276643BQ34019573-F9685D93-5F93-48A2-8FDD-980E5F13D129Q34023999-487B3854-3485-4E3C-BE10-1381CF693350Q34028431-A3F99A95-6833-4E03-B56E-5C135118D1F6Q34231719-21EF6691-D666-47FE-9A85-C0663429BAA2Q34247711-43951966-69A9-4765-9618-16CF0830D845Q34429295-15D737CF-0802-483A-B94D-7F494A01688CQ34524896-BEA96A65-1EFF-497F-9AB4-7F77BAC0395EQ34536089-69F70016-E994-42B3-95A0-D39C249E0037Q34606612-C9A2B572-AD0B-49AA-9C62-BB5124717166Q34612917-610532C1-AA8E-49C2-9B81-DB7F72EA60E7Q35122796-4DCCB46D-55FD-494E-A483-FAF4E94EF570Q35678770-5BB1A856-E3A8-4A97-9C8F-9FD183EEB4D5Q35930094-5B5F9155-E804-4A8C-947F-F55426B2CEEBQ36057960-D6946204-E320-4379-B243-2D54B947A2B8Q36279024-E38DEC0A-0C7D-4625-B56B-852DDA8F02C3Q36447081-6CA4EDB5-69F5-43FA-B7B0-CF635515AA46Q36476481-09E5C6EC-DCA1-4336-9247-0D1192406544Q36626501-C4BCA270-7021-4D18-88CB-47849F463AA2Q36893511-61CD39AB-48B0-4B0B-8863-13A6CBA2F9A6Q36912778-34E04E80-4C32-492C-90B6-E4F921582430Q36978586-77364E85-F9E3-414E-9810-34012300FCE4Q36990269-A0FC24FE-1123-4AD8-8B3C-9BE8EC87CCE8Q36992061-83FBD020-6C17-4391-BB82-8C391221A9DDQ36999759-848E678B-8C4A-4123-B683-E757CA77E3C4Q37107118-27A353B1-1915-4E28-8B76-121440584CB7Q37148698-D0DC3E16-2B6D-428E-9919-242FCBC97B95Q37150745-67D2D7D9-FEB1-4D13-8E8C-0892EEBA3D12Q37164807-5DB9DEEA-DF30-480D-AF33-8D13BF378A16
P2860
Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Site-specific increases in per ...... n a model of neuropathic pain.
@ast
Site-specific increases in per ...... n a model of neuropathic pain.
@en
type
label
Site-specific increases in per ...... n a model of neuropathic pain.
@ast
Site-specific increases in per ...... n a model of neuropathic pain.
@en
prefLabel
Site-specific increases in per ...... n a model of neuropathic pain.
@ast
Site-specific increases in per ...... n a model of neuropathic pain.
@en
P2093
P2860
P50
P921
P1433
P1476
Site-specific increases in per ...... in a model of neuropathic pain
@en
P2093
Andre V Guerrero
Hirotate Iwase
Igor Spigelman
Kym F Faull
Navapoln Ramakul
Takeshi Ono
P2860
P304
P356
10.1016/J.PAIN.2006.06.016
P407
P577
2006-07-14T00:00:00Z